Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Kwality Pharmaceuticals Ltd
Your Vote -
Buy
60.00%
Hold
0.00%
Sell
40.00%
60.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Kwality Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Kwality Pharmaceutic - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Kwality Pharmaceutic - Regularization And Reappointment Of Directors At AGM
-
Kwality Pharmaceutic - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Kwality Pharmaceutic - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Kwality Pharmaceutic - Appointment Of Secretarial Auditors Of The Company
-
Kwality Pharmaceutic - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Kwality Pharmaceutic - Kwality Pharma Receives Product Registration For Bleomycin 15 IU In Mexico For Sale And Distribution.
-
Kwality Pharmaceutic - Notice Of 42Nd AGM Of The Company Scheduled To Be Held On 09Th September 2025
-
Kwality Pharmaceutic - Reg. 34 (1) Annual Report.
-
Kwality Pharmaceutic - Intimation Of Book Closure
-
Kwality Pharmaceutic - 42Nd Annual General Meeting (AGM) Of The Shareholders Of The Company Will Be Held On Tuesday, The 09T
-
Kwality Pharmaceutic - Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM
-
Kwality Pharmaceutic Q1 net profit jumps 42.53% at Rs 11.93 cr
-
Kwality Pharmaceutic - Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30, 2025
-
Kwality Pharmaceutic - Board Meeting Outcome for Submission Of Standalone And Consolidated Unaudited Financial Results For Th
-
Kwality Pharmaceutic - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Finan
-
Kwality Pharmaceutic - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Kwality Pharmaceutic - Announcement under Regulation 30 (LODR)-Change in Management
-
Kwality Pharmaceutic has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
-
Kwality Pharmaceutic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Kwality Pharmaceuticals
Key fundamentals
Evaluate the intrinsic value of Kwality Pharmaceuticals Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | March-21 |
---|---|---|---|---|---|
Assets | 378.2896 | 324.064 | 292.289 | 225.8491 | 97.2286 |
Liabilities | 378.2896 | 324.064 | 292.289 | 225.8491 | 97.2286 |
Equity | 10.3762 | 10.3762 | 10.3762 | 10.3762 | 10.3762 |
Gross Profit | 80.4432 | 66.6333 | 60.2887 | 171.7244 | 29.2599 |
Net Profit | 39.8897 | 23.9839 | 19.4688 | 120.0466 | 15.415 |
Cash From Operating Activities | 52.7737 | 43.3473 | 42.1877 | 63.0607 | 26.3559 |
NPM(%) | 10.77 | 7.8 | 7.75 | 26.31 | 5.89 |
Revenue | 370.197 | 307.1718 | 250.9947 | 456.1316 | 261.5027 |
Expenses | 289.7538 | 240.5385 | 190.706 | 284.4072 | 232.2428 |
ROE(%) | 16.54 | 9.95 | 8.07 | 49.8 | 6.39 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Kwality Pharmaceuticals Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 801.00 | -1.01 | 72.72 | 546.66 | 301.39 | 0.62 |
Lotus Eye Hospital and Institute Ltd | 119.50 | -2.85 | 389.61 | 1991.97 | 3.55 | 0.00 |
Bharat Immunological and Biologicals Corporation Ltd | 22.01 | 0.23 | 0.00 | 4136.00 | -39.50 | 0.00 |
Astec Lifesciences Ltd | 823.00 | -1.44 | 0.00 | 1878.48 | -604.77 | 0.00 |
Company Info
The Company was originally incorporated as Kwality Pharmaceuticals Private Limited on May 04, 1983 with the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Further the name of the Company was changed to Kwality Pharmaceuticals Limited vide a fresh certificate of incorporation dated December 28, 2015 issued by the Registrar of Companies, Chandigarh. The Corporate Identification Number is U24232PB1983PLC005426. The Promoters of the Company are Mr. Ramesh Arora and Mr. Ajay Arora. The Company is primarily engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. The Company does not have RoC filings with respect to Form 2 made in the period prior to 2003, in order to ascertain allotments made during the period from May 04, 1983, till March 29, 2003. However, the Company has maintained Register of Members since inception and we have relied on the limited information available in the Minute Book and Register of Members of the Company. The relevant documents are also not available/destroyed at the office of the RoC Chandigarh as certified by Rishi Mittal & Associates, Company Secretaries, dated May 30, 2016. Therefore, the Company is unable to provide any disclosures or make any confirmations on all of the aforementioned matters. The disclosures pertaining to the aforementioned matters currently made in this Prospectus are subject to information readily available from public domains and other limited records. The Registered Office of the Company is situated at Village Nagkalan, Majitha Road, Amritsar - 143601. Major Events and Milestones : 1983 -Incorporation of the Company on May 04, 1983 2007 -Received ISO Certification 2008 -Commencement of new manufacturing unit at Jassur in Himachal Pradesh 2009 -Received status of Star Export House Certificate 2012 -Turnover increased by 75% 2013 -Incorporation of Subsidiary Company in Africa 2014 -Received WHO certification 2016 -Kwality Pharmaceuticals are listed and admitted to dealings on the Exchange in the list of 'MT' Group Securities. 2017 The Company has allotted on October 13, 2017, 51,88,099 Equity Shares of Rs. 10/- each, as Bonus Shares in the ratio of 1:1 to the shareholders whose names appear on the Register of Members/Depositories as on record date i.e. October 12, 2017. 2024 -The Company Received Its First Biological Product Permission For Manufacturing And Sale Of Pegylated-Aspa.
The Company was originally incorporated as Kwality Pharmaceuticals Private Limited on May 04, 1983 with the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Further the name of the Company was changed to Kwality Pharmaceuticals Limited vide a fresh certificate of incorporation dated December 28, 2015 issued by the Registrar of Companies, Chandigarh. The Corporate Identification Number is U24232PB1983PLC005426. The Promoters of the Company are Mr. Ramesh Arora and Mr. Ajay Arora. The Company is primarily engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. The Company does not have RoC filings with respect to Form 2 made in the period prior to 2003, in order to ascertain allotments made during the period from May 04, 1983, till March 29, 2003. However, the Company has maintained Register of Members since inception and we have relied on the limited information available in the Minute Book and Register of Members of the Company. The relevant documents are also not available/destroyed at the office of the RoC Chandigarh as certified by Rishi Mittal & Associates, Company Secretaries, dated May 30, 2016. Therefore, the Company is unable to provide any disclosures or make any confirmations on all of the aforementioned matters. The disclosures pertaining to the aforementioned matters currently made in this Prospectus are subject to information readily available from public domains and other limited records. The Registered Office of the Company is situated at Village Nagkalan, Majitha Road, Amritsar - 143601. Major Events and Milestones : 1983 -Incorporation of the Company on May 04, 1983 2007 -Received ISO Certification 2008 -Commencement of new manufacturing unit at Jassur in Himachal Pradesh 2009 -Received status of Star Export House Certificate 2012 -Turnover increased by 75% 2013 -Incorporation of Subsidiary Company in Africa 2014 -Received WHO certification 2016 -Kwality Pharmaceuticals are listed and admitted to dealings on the Exchange in the list of 'MT' Group Securities. 2017 The Company has allotted on October 13, 2017, 51,88,099 Equity Shares of Rs. 10/- each, as Bonus Shares in the ratio of 1:1 to the shareholders whose names appear on the Register of Members/Depositories as on record date i.e. October 12, 2017. 2024 -The Company Received Its First Biological Product Permission For Manufacturing And Sale Of Pegylated-Aspa.
Read More
Parent Organisation
Kwality Pharmaceuticals Ltd.
Founded
04/05/1983
Managing Director
Mr.Ramesh Arora
NSE Symbol
FAQ
The current price of Kwality Pharmaceuticals Ltd is
The 52-week high for Kwality Pharmaceuticals Ltd is
The market capitalization of Kwality Pharmaceuticals Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Kwality Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Kwality Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Kwality Pharmaceuticals Ltd shares.
The CEO of Kwality Pharmaceuticals Ltd is Mr.Ramesh Arora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.